| News

Switzerland Innovation Park Basel Area offre des ateliers et séminaires pour innover

11.06.2019

Venez innover avec nous ! Tel est le slogan pour les ateliers et séminaires qui seront organisés dans le Switzerland Innovation Park Basel Area du Jura pour les entreprises jurassiennes. Un programme alléchant qui traitera autant de sujets de diversification que de thématiques telles que l’intelligence artificielle ou le design thinking. A coup sûr, ce sont des sujets qui vous intéresseront.

Switzerland Innovation Park Jura Workshops

Le Switzerland Innovation Park Basel Area, antenne du Jura, se positionne comme un accélérateur de développement de projets pour les entreprises jurassiennes. Son ouverture est programmée pour cet automne et permettra aux PME, start-ups et institutions locales de s’y installer, de venir travailler et échanger dans des locaux de 1200  mètres carrés comprenant des bureaux privés et partagés, des espaces communs et des surfaces modulables.

Pour aider les entreprises jurassiennes à relever les défis liés à la transformation industrielle, un riche programme de séminaires et d’ateliers sera mis sur pieds à partir de septembre 2019. Retrouvez plus d’informations sur toutes les thématiques proposées dans le flyer.

En cas de questions, n’hésitez pas à prendre contact avec M. Sébastien Meunier, Directeur Industrial Transformation and Entrepreneurship au T+41 61 295 50 15 ou par email à sebastien.meunier@baselarea.swiss.

Nous nous réjouissons d’accueillir vos inscriptions!

Pour plus d’informations : www.switzerland-innovation.com/baselarea

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

VectivBio secures investments totaling 110 million dollars
Basel Area Business & Innovation, Innovation, Invest

VectivBio secures investments totaling 110 million dollars

The Basel-based biotechnology firm VectivBio has received a capital injection of 110 million US dollars from both new and existing...

Read More
Polyphor receives up to 18 million dollars for development of antibiotics
Basel Area Business & Innovation, Innovation, Invest

Polyphor receives up to 18 million dollars for development of antibiotics

The Allschwil-based company Polyphor has received a second funding award from the global consortium CARB-X to combat antimicrobial resistance. Polyphor...

Read More
What makes Switzerland’s economy resilient in face of COVID pandemic
Basel Area Business & Innovation, Invest

What makes Switzerland’s economy resilient in face of COVID pandemic

The COVID-19 pandemic has hit economies worldwide – and we have not yet overcome it. However, Switzerland is among the...

Read More
DayOne Accelerator applications open
Basel Area Business & Innovation, Innovation

DayOne Accelerator applications open

We are excited to announce the opening of the call for the DayOne Accelerator, now in its 3rd year!

Read More
Matériaux Sabag printing concrete elements
Basel Area Business & Innovation, Innovation, Invest

Matériaux Sabag printing concrete elements

The Jura-based company Matériaux Sabag is now using a 3D printing solution to produce its concrete elements. This approach allows...

Read More
Six companies win the i4Challenge
Basel Area Business & Innovation, Innovation

Six companies win the i4Challenge

The i4Challenge expert jury has selected six winners from 18 finalists. The Industry 4.0 solutions range from 3D printing, IoT,...

Read More
Monte Rosa Therapeutics banks 96 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Monte Rosa Therapeutics banks 96 million US dollars

The Basel-based biotechnology firm Monte Rosa Therapeutics has raised a total of 96 million US dollars after closing a successful...

Read More
Roche launches new coronavirus antibody test
Basel Area Business & Innovation, Innovation, Invest

Roche launches new coronavirus antibody test

Roche is launching on the market a new antibody test to determine coronavirus infections. This should help with the development...

Read More
Investors see great potential in Polyneuron
Basel Area Business & Innovation, Innovation, Invest

Investors see great potential in Polyneuron

The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised a total of 36.5 million...

Read More
Lonza set to manufacture coronavirus drug for Humanigen
Basel Area Business & Innovation, Innovation, Invest

Lonza set to manufacture coronavirus drug for Humanigen

The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza...

Read More
1 2 3 21

Do you have a question? We'd like to hear from you.